Supply of apixaban tablets under the Amgros 2027 framework agreement

Summary

Amgros I/S is procuring apixaban tablets for Danish hospital pharmacies under a framework agreement divided into one lot. The estimated quantities are 145,524 units of 2.5 mg tablets and 355,795 units of 5 mg tablets; actual consumption may differ substantially. The framework agreement has an estimated maximum value of DKK 31.2 million and an ordinary purchasing period from 1 April 2027 to 31 March 2028, with an option to extend by up to 12 months. It is non-exclusive and does not oblige the buyer to purchase a minimum quantity.